Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Lacticaseibacillus rhamnosus CNCM I-3690

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Lacticaseibacillus rhamnosus CNCM I-3690 is a probiotic strain that has been studied for its potential health benefits. Research has shown that this strain exhibits protective effects on intestinal barrier function, such as reducing barrier hyper-permeability in mice and decreasing subjective academic stress in healthy adults
Laval et al. 2015 Gut Microbes 6(1): 1-9
Wauters et al. 2022 Gut Microbes 14(1): 2031695

It is also known for its anti-inflammatory properties and its ability to counterbalance gut barrier dysfunction
Martín et al. 2023 Sci Rep 13: 6114

Lacticaseibacillus rhamnosus CNCM I-3690 induces …

References (Sources)

Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans
Grompone et al. 2012 PLoS ONE 7(12): e52493
Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice
Laval et al. 2015 Gut Microbes 6(1): 1-9
Lactobacillus rhamnosus CNCM I-3690 decreases subjective academic stress in healthy adults: a randomized placebo-controlled trial
Wauters et al. 2022 Gut Microbes 14(1): 2031695
Over-production of exopolysaccharide by Lacticaseibacillus rhamnosus CNCM I-3690 strain cutbacks its beneficial effect on the host
Martín et al. 2023 Sci Rep 13: 6114
The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response
Martin et al. 2019 Sci. Rep. 9: 5398

AI Chat

7/1/2026

Chat with our artificial intelligence: